메뉴 건너뛰기




Volumn 8, Issue 2, 2011, Pages 65-66

Prostate cancer in 2010: GSU: Misclassification or biological progression?

Author keywords

[No Author keywords available]

Indexed keywords

CANCER CLASSIFICATION; CANCER EPIDEMIOLOGY; CANCER GROWTH; CLINICAL PRACTICE; GLEASON SCORE; GLEASON SUM UPGRADING; HUMAN; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; REVIEW;

EID: 79951484414     PISSN: 17594812     EISSN: 17594820     Source Type: Journal    
DOI: 10.1038/nrurol.2010.247     Document Type: Review
Times cited : (3)

References (10)
  • 1
    • 79954456907 scopus 로고    scopus 로고
    • Surgical management after active surveillance for low-risk prostate cancer: Pathological outcomes compared with men undergoing immediate treatment
    • doi:10.1111/j.1464-410.X.2010.09589.x
    • Dall'era, M. A. et al. Surgical management after active surveillance for low-risk prostate cancer: pathological outcomes compared with men undergoing immediate treatment. BJU Int. doi:10.1111/j.1464-410.X.2010.09589.x.
    • BJU Int.
    • Dall'Era, M.A.1
  • 2
    • 33645760008 scopus 로고    scopus 로고
    • Development and internal validation of a nomogram predicting the probability of prostate cancer Gleason sum upgrading between biopsy and radical prostatectomy pathology
    • Chun, F. K. et al. Development and internal validation of a nomogram predicting the probability of prostate cancer Gleason sum upgrading between biopsy and radical prostatectomy pathology. Eur. Urol. 49, 820-826 (2006).
    • (2006) Eur. Urol. , vol.49 , pp. 820-826
    • Chun, F.K.1
  • 3
    • 78649362120 scopus 로고    scopus 로고
    • EaU guidelines on prostate cancer. part 1: Screening, diagnosis, and treatment of clinically localised disease
    • Heidenreich, A. et al. EaU guidelines on prostate cancer. part 1: screening, diagnosis, and treatment of clinically localised disease. Eur. Urol. 59, 61-71 (2011).
    • (2011) Eur. Urol. , vol.59 , pp. 61-71
    • Heidenreich, A.1
  • 4
    • 65049088199 scopus 로고    scopus 로고
    • Biopsy core number represents one of foremost predictors of clinically significant gleason sum upgrading in patients with low-risk prostate cancer
    • Capitanio, U. et al. Biopsy core number represents one of foremost predictors of clinically significant gleason sum upgrading in patients with low-risk prostate cancer. Urology 73, 1087-1091 (2009).
    • (2009) Urology , vol.73 , pp. 1087-1091
    • Capitanio, U.1
  • 5
    • 56249097867 scopus 로고    scopus 로고
    • Outcomes of men with screen-detected prostate cancer eligible for active surveillance who were managed expectantly
    • Van den Bergh, R. C. et al. Outcomes of men with screen-detected prostate cancer eligible for active surveillance who were managed expectantly. Eur. Urol. 55, 1-8 (2009).
    • (2009) Eur. Urol. , vol.55 , pp. 1-8
    • Van Den Bergh, R.C.1
  • 6
    • 77952543434 scopus 로고    scopus 로고
    • Upgrading of Gleason score 6 prostate cancers on biopsy after prostatectomy in the low and intermediate tPSa range
    • Colleselli, D. et al. Upgrading of Gleason score 6 prostate cancers on biopsy after prostatectomy in the low and intermediate tPSa range. Prostate Cancer Prostatic Dis. 13, 182-185 (2010).
    • (2010) Prostate Cancer Prostatic Dis. , vol.13 , pp. 182-185
    • Colleselli, D.1
  • 7
    • 80052943704 scopus 로고    scopus 로고
    • Clinical and pathologic predictors of Gleason sum upgrading in patients after radical prostatectomy: Results from a single institution series
    • doi:10.1016/j.urolonc.2009.07.003
    • Tilki, D. et al. Clinical and pathologic predictors of Gleason sum upgrading in patients after radical prostatectomy: results from a single institution series. Urol. Oncol. doi:10.1016/j.urolonc.2009.07.003.
    • Urol. Oncol.
    • Tilki, D.1
  • 8
    • 75149137443 scopus 로고    scopus 로고
    • A nomogram for predicting upgrading in patients with low-and intermediate-grade prostate cancer in the era of extended prostate sampling
    • Moussa, A. S. et al. A nomogram for predicting upgrading in patients with low-and intermediate-grade prostate cancer in the era of extended prostate sampling. BJU Int. 105, 352-358 (2010).
    • (2010) BJU Int. , vol.105 , pp. 352-358
    • Moussa, A.S.1
  • 10
    • 55749109028 scopus 로고    scopus 로고
    • Currently used criteria for active surveillance in men with low-risk prostate cancer: An analysis of pathologic features
    • Suardi, N. et al. Currently used criteria for active surveillance in men with low-risk prostate cancer: an analysis of pathologic features. Cancer 113, 2068-2072 (2008).
    • (2008) Cancer , vol.113 , pp. 2068-2072
    • Suardi, N.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.